Krka Focuses On Extending Cardiovascular And Oncology Range
As Company Invests In Production And Laboratory Capacities
After reporting a profitable 2020, Slovenia’s Krka is looking to expand its cardiovascular and oncology portfolio, while adding to its diabetes and central nervous system range as well. The firm has also started manufacturing in China for the local market.
